TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/07/2025
Voltar para busca
Dado oficial do USPTO
ISOMORPHIC LABORATORIES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ISOMORPHIC LABORATORIES
ST13
US500000097170047Classe
9, 42
Pedido
97170047
Registro
7781597
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
19/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 42
Data de depósito
13/12/2021
Data de registro
06/05/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/05/2025
Última transação
19/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
London, GB
Examinador
DUENAS, TAYLOR
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Isomorphic Labs Limited
Representantes
Cynthia Johnson Walden Fish & Richardson P.C.
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer software using artificial intelligencemachine learningdeep learningreinforcement learning for predicting protein structurediscovering pharmaceutical drugsdeveloping pharmaceutical products; downloadable computer softwarecomputer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methodsnatural language processingnatural language understandingdialog systemsvoice and speech recognition and text to speech systemsnatural language human-machine interfacespredictive assistance technologies for protein structure predictionpharmaceutical drug discoverypharmaceutical product development
Classe 42
Software as a service (SAAS) services featuring software using artificial intelligencemachine learningdeep learningreinforcement learning for protein structure predictionpharmaceutical drug discoverypharmaceutical product development; advanced product researchdesign and development in the field of artificial intelligence for protein structure predictionpharmaceutical drug discoverypharmaceutical product development; research and development in the fields of artificial intelligencemachine learningdeep learningreinforcement learning technologies for protein structure predictionpharmaceutical drug discoverypharmaceutical product development; technology research in the field of artificial intelligencemachine learningdeep learningreinforcement learning for use in protein structure predictionpharmaceutical drug discoverypharmaceutical product development; providing onlinenon-downloadable computer software platforms using artificial intelligencemachine earningdeep learningreinforcement learning for protein structure predictionpharmaceutical drug discoverypharmaceutical product development; testing of computing methodscomputer software algorithmscomputer softwarecomputer hardware for protein structure predictionpharmaceutical drug discoverypharmaceutical product development; scientificpharmaceuticalmedical research; scientific research in the field of computer software using artificial intelligencemachine learningdeep learningreinforcement learning for medical researchpharmaceutical researchprotein structure predictionpharmaceutical drug discoverypharmaceutical product development; product research and development; medicalpharmaceuticalscientific research in the field of protein structure predictionpharmaceutical drug discoverypharmaceutical product developmentcomputational biology; scientific and technological servicesscientific research in the fields of analytics and data miningdata analysisdata transformationdata visualizationstatistical analysisartificial intelligencemachine learning and virtual realitysciencechemistryphysicsbiology and scientific researchall for protein structure predictionpharmaceutical drug discoverypharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligencemachine learningdeep learningreinforcement learningbuilding neural networksdata tree searchhigh performance computingdistributed computingcloud computinganalytics and data miningvirtual realityaugmented realitychemistryphysicsbiologyall for protein structure predictionpharmaceutical drug discoverypharmaceutical product development; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/07/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/07/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/05/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/03/2025
PUBO
PUBLISHED FOR OPPOSITION
18/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/03/2025
OTHE
CASE RETURNED TO EXAMINATION
30/01/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
30/01/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
27/01/2025
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
27/01/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/01/2025
EX2G
SOU EXTENSION 2 GRANTED
11/01/2025
APET
ASSIGNED TO PETITION STAFF
06/01/2025
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
20/11/2024
EXT2
SOU EXTENSION 2 FILED
19/11/2024
EEXT
SOU TEAS EXTENSION RECEIVED
19/11/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/05/2024
EX1G
SOU EXTENSION 1 GRANTED
17/05/2024
EXT1
SOU EXTENSION 1 FILED
17/05/2024
EEXT
SOU TEAS EXTENSION RECEIVED
17/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/04/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/04/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/04/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
21/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/09/2023
PUBO
PUBLISHED FOR OPPOSITION
26/09/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/09/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
21/08/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
18/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/08/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
14/08/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/08/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
14/08/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/08/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
25/05/2023
GNFR
FINAL REFUSAL E-MAILED
25/05/2023
CNFR
FINAL REFUSAL WRITTEN
25/05/2023
DOCK
ASSIGNED TO EXAMINER
03/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/03/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/09/2022
GNRT
NON-FINAL ACTION E-MAILED
21/09/2022
CNRT
NON-FINAL ACTION WRITTEN
21/09/2022
DOCK
ASSIGNED TO EXAMINER
20/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/12/2021
NWAP
NEW APPLICATION ENTERED
16/12/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ISOMORPHIC LABORATORIES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.